Page 39 - Poster Sessions] CUA 2022 Annual Meeting Abstracts

Poster 5: Sexual Dysfunction/Infertility, Pelvic Pain, Infection, Pediatrics

percent underwent repeat SI in the following year. A total of 217 patients
with NG and 434 with SO developed MDRO post-SI, within 2.9 and 2.7
prescriptions, respectively. Patients with pre-SI MDRO were more likely to
receive antibiotic prescriptions in the following year (NG 5.5 vs. SO 5.7
vs. MDRO 7.0) and received ciprofloxacin 24% of the time. Unplanned
emergency visits were similar post-SI (4.0 vs. 4.0 vs. 4.7, p=0.23) but
pre-SI MDRO had significantly more emergency visits in the year prior
(2.6 vs. 3.1 vs. 4.3, p<0.0001).
Conclusions: Ureteral stents pose a significant risk for developing MDRO,
even when starting with negative urine cultures. Patients with MDRO are
more likely to be re-stented, receive more antibiotics, and present to the
emergency department. Given these complicating features, stented patients
warrant careful consideration of their microbiology and antibiotic exposures.
MP-5.10. Figure 2. Change in ICSI and ICPI after three months of treatment in
the first two patients. MP-5.12
Mini-incision and plication cure hydrocele technique: A less
MP-5.11 invasive surgical variation
1,3
Population-based study on the incidence and risks of multidrug- Anthony-Joe Nassour 1,2,3 , Darius Ashrafi , Dinesl Patel 1,2,3
resistant organisms in patients with ureteric stents 1 Department of Urology, Bankstown-Lidcombe Hospital, Sydney,
2
Runhan Ren , Zoe Hsu , Erik Youngson , Shubhadip De 1 Australia; Department of Urology, Canterbury Hospital, Sydney, Australia;
2
2
1
2
1 Division of Urology, University of Alberta, Edmonton, AB, Canada; Data 3 University of New South Wales, Sydney, Australia
Integration, Management and Reporting Group, University of Alberta, Introduction: Idiopathic hydroceles are the commonest cause of chronic
Edmonton, AB, Canada benign scrotal swelling, affecting 1% of adult men. The popular Jaboulay
Introduction: Due to the overlapping symptoms between ureteric stents technique (1902) is curative and remains the standard for most surgeons.
and infectious cystitis, patients are at increased risk of antibiotic over- However, it is associated with significant morbidity and has a reported
exposure. Our objective was to assess provincial trends in antibiotic and recurrence rate of 5%. Various minimally invasive approaches have been
multidrug-resistant organisms (MDRO) in patients with ureteric stents. described with fewer reported complications but limited efficacy, with
Methods: A retrospective, provincial cohort of patients undergoing unacceptable recurrence rates requiring multiple treatments. We describe
ureteric stent insertion (SI) was created using administrative and clinical a novel mini-incision and plication (MIP) cure hydrocele technique and
data through Alberta’s Data Integration, Management, and Reporting report on our morbidity and recurrence.
unit (2013–2018). Those with concurrent extirpative and reconstructive Methods: A retrospective, single-surgeon audit was conducted on patients
surgeries were excluded. Data one year pre- and post-SI was collected. that underwent the MIP at two hospitals in Sydney between January
Patients with urine cultures (UC) growing MDRO (microbes resistant to 2013 and December 2020. This technique is performed using a standard
>3 antibiotics) were identified and analyzed based on pre-SI UC status minor-ops tray. Key operative steps include: small midline incision, early
(no growth [NG], sensitive organisms [SO], and MDRO). drainage of hydrocele, complete incision of the anterior hydrocele wall,
Results: A total of 13 820 SI were completed over the five-year period. delivery of testis, eversion and posterior plication of the bisected hydro-
MDRO increased from 1.2% (n=164) to 5.9% (n=815) after SI; 42% of cele sac, repositioning of testis, and standard closure (Figure 1). Routine
these stents were placed for hydronephrosis and 21% for stones. Forty postoperative followup takes place at one and three months. Recurrence

MP-5.12. Figure 1.

CUAJ • June 2022 • Volume 16, Issue 6(Suppl1) S61